Apellis Pharmaceuticals, Inc.【APLS】 業績推移・財務諸表

(単位:千ドル) 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 1Q22 2Q22 3Q22 1Q23 2Q23 3Q23 1Q24 2Q24 3Q24 1Q25
売上高 - - - - - - - - - - - - 646 - - 600 5,650 14,381 16,322 22,056 44,846 94,969 110,399 172,325 199,685 196,830 166,797
売上成長率(%) - - - - - - - - - - - - - - - - -
研究開発費 9,517 - 17,402 27,537 29,539 - 40,479 50,698 51,319 - 69,282 87,094 93,207 - 84,012 95,943 87,733 90,945 101,661 95,207 110,027 95,658 79,421 84,701 77,947 88,569 86,420
販売管理費 - - - - - - - - - - - - - - - - - - - - - - - 129,505 128,081 121,984 129,345
営業費用 - - - - - - - - - - - - 130,198 - - 194,910 133,645 143,379 164,946 174,994 219,929 215,410 247,479 234,415 229,128 244,110 250,125
営業利益 -11,590 -17,569 -21,439 -33,486 -35,805 -37,197 -48,651 -63,477 -69,948 -105,941 -98,786 -115,508 -129,552 130,120 -124,591 -194,287 -127,995 -128,998 -148,624 -152,938 -175,083 -120,441 -137,080 -62,090 -29,443 -47,280 -83,328
営業利益率 (%) - - - - - - - - - - - - - -
経常(税引前)利益 - - - - - - - - - - - - - - - - - -137,727 -155,491 -190,823 -177,496 -121,843 -140,004 -66,253 -37,543 -56,853 -91,884
経常(税引前)利益率(%) - - - - - - - - - - - - - - - - - -957.7 -952.65 -865.18 -395.79 -128.3 -126.82 -38.45 -18.8 -28.88 -55.09
法人税等合計 - - - - - - - - - - - - - - - - - 1,200 500 400 300 200 233 200 100 600 300
実効税率(%) - - - - - - - - - - - - - - - - -
純利益 -11,574 -18,256 -21,737 -33,335 -35,973 -36,460 -50,575 -71,091 -69,825 -113,218 -168,822 -118,617 -135,700 78,265 -183,659 -219,191 -195,571 -138,935 -155,977 -191,269 -177,778 -122,037 -140,237 -66,423 -37,657 -57,445 -92,225
純利益率(%) - - - - - - - - - - - - - -
一株あたり利益 - - - - - - - - - - - - - - - - - - -1.46 -1.75 -1.56 -1.02 -1.17 -0.54 -0.3 -0.46 -0.74
希薄化後一株あたり利益 - - - - - - - - - - - - - - - - - - -1.46 -1.75 -1.56 -1.02 -1.17 -0.54 -0.3 -0.46 -0.74